Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$129,936
-2.16%
Shares
Shares Volume: 5,414 Shares
Average Share Price: $24
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Dec 29 2023
traded on Dec 27 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 245,131 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $163,455.73 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 5 / 38 |
| P/S VALUE RATIO | 0.939 |
| AVERAGE SALE VALUE | $694,511.96 |
| COMPANY PREVIOUS TRADES |